Class information for:
Level 2: ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1512 6953 45.0 87%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
261 41136 GENE DELIVERY//GENE THERAPY//ANTIMICROBIAL PEPTIDE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
1133 2735 ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS
3583 1877 CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE
11200 935 HSV1 TK//FIAU//RADIOCHEM CYCLOTRON CORE IL
15670 629 CB1954//ADEPT//ANTIBODY DIRECTED ENZYME PRODRUG THERAPY
16418 590 BACTOFECTION//BACTERIAL THERAPY//SALMONELLA TYPHIMURIUM A1 R
27507 187 GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ONCOLYTIC VIRUS Author keyword 339 74% 4% 251
2 VIROTHERAPY Author keyword 164 66% 2% 152
3 CYTOSINE DEAMINASE Author keyword 155 67% 2% 139
4 CANCER GENE THERAPY Journal 134 25% 7% 461
5 ONCOLYTIC ADENOVIRUS Author keyword 127 64% 2% 126
6 ONCOLYTIC Author keyword 106 68% 1% 93
7 HERPES SIMPLEX VIRUS THYMIDINE KINASE Author keyword 102 65% 1% 96
8 ONCOLYSIS Author keyword 97 70% 1% 80
9 SUICIDE GENE THERAPY Author keyword 95 56% 2% 114
10 CB1954 Author keyword 89 92% 1% 35

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ONCOLYTIC VIRUS 339 74% 4% 251 Search ONCOLYTIC+VIRUS Search ONCOLYTIC+VIRUS
2 VIROTHERAPY 164 66% 2% 152 Search VIROTHERAPY Search VIROTHERAPY
3 CYTOSINE DEAMINASE 155 67% 2% 139 Search CYTOSINE+DEAMINASE Search CYTOSINE+DEAMINASE
4 ONCOLYTIC ADENOVIRUS 127 64% 2% 126 Search ONCOLYTIC+ADENOVIRUS Search ONCOLYTIC+ADENOVIRUS
5 ONCOLYTIC 106 68% 1% 93 Search ONCOLYTIC Search ONCOLYTIC
6 HERPES SIMPLEX VIRUS THYMIDINE KINASE 102 65% 1% 96 Search HERPES+SIMPLEX+VIRUS+THYMIDINE+KINASE Search HERPES+SIMPLEX+VIRUS+THYMIDINE+KINASE
7 ONCOLYSIS 97 70% 1% 80 Search ONCOLYSIS Search ONCOLYSIS
8 SUICIDE GENE THERAPY 95 56% 2% 114 Search SUICIDE+GENE+THERAPY Search SUICIDE+GENE+THERAPY
9 CB1954 89 92% 1% 35 Search CB1954 Search CB1954
10 ONCOLYTIC VIROTHERAPY 83 75% 1% 60 Search ONCOLYTIC+VIROTHERAPY Search ONCOLYTIC+VIROTHERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VIRUS THYMIDINE KINASE 261 61% 4% 275
2 ONYX 015 248 78% 2% 166
3 VIROTHERAPY 220 77% 2% 151
4 COMPETENT ADENOVIRUS 191 92% 1% 77
5 THYMIDINE KINASE GENE 191 35% 6% 439
6 CYTOSINE DEAMINASE 164 54% 3% 214
7 CYTOSINE DEAMINASE GENE 138 68% 2% 121
8 VIRAL THERAPY 134 86% 1% 68
9 SUICIDE GENE THERAPY 131 52% 3% 178
10 EXPERIMENTAL BRAIN TUMORS 125 53% 2% 166

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANCER GENE THERAPY 134 25% 7% 461

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Oncolytic virotherapy 2012 203 158 63%
New viruses for cancer therapy: meeting clinical needs 2014 27 134 58%
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress 2007 216 44 91%
Molecular imaging in living subjects: seeing fundamental biological processes in a new light 2003 1112 212 36%
Going viral with cancer immunotherapy 2014 21 120 58%
Engineering the perfect (bacterial) cancer therapy 2010 95 116 87%
Suicide gene therapy in cancer: Where do we stand now? 2012 47 164 65%
Viruses for Tumor Therapy 2014 8 28 86%
Oncolytic viral therapies - the clinical experience 2005 170 58 84%
Recent progress in the battle between oncolytic viruses and tumours 2005 296 117 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANC GENE THER Y GRP 68 60% 1.1% 75
2 SAN DIEGO SCI 63 70% 0.8% 53
3 HUMAN GENE THER Y 25 18% 1.8% 124
4 FINNISH MOL MED 24 53% 0.4% 31
5 RADIOCHEM CYCLOTRON CORE IL 19 76% 0.2% 13
6 IMMUNOVIROTHER Y 18 83% 0.1% 10
7 MOL NEUROSURG 16 31% 0.6% 44
8 REBECCA JOHN MOO COMPREHENS CANC 16 45% 0.4% 27
9 GENE CELL THER Y 15 33% 0.5% 38
10 XINYUAN MED BIOTECHNOL 15 34% 0.5% 37

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000023097 GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE
2 0.0000020377 E1A//BIOL MOL ELADIO VINUELA//PHAGE PHI 29
3 0.0000011418 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY
4 0.0000009552 MIDKINE//PLEIOTROPHIN//HB GAM
5 0.0000009315 BINUCLEATED LYMPHOCYTES//HUMANIZED MICE//CHEMOSENSITIVITY TEST
6 0.0000006668 BIOLUMINESCENCE//LAMPYRIDAE//COELENTERAZINE
7 0.0000006453 P73//MDM2//P53
8 0.0000006374 UNITE INTERACT BACTERIES CELLULES//LISTERIOLYSIN O//USC2020
9 0.0000006078 ORTHOPOXVIRUS//POXVIRUS//VACCINIA VIRUS
10 0.0000006026 CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA